当前位置:首页 - 行情中心 - 金域医学(603882) - 财务分析

金域医学

(603882)

  

流通市值:263.56亿  总市值:265.32亿
流通股本:4.66亿   总股本:4.69亿

金域医学(603882)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.67亿元,每股收益1.23元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益867675.85万元,未分配利润614026.01万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1216305.24万元,负债348629.40万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入6,309,622,119.424,308,511,708.022,117,566,265.1415,476,074,538.17
营业总成本5,575,699,748.493,676,616,414.731,821,458,551.6811,942,259,979.49
营业利润642,415,135.81336,305,005.29164,440,700.83,347,234,349.58
利润总额627,163,774.35325,929,111.95157,267,545.513,320,729,711.05
净利润566,649,689.09282,235,598.93140,616,978.252,842,983,879.39
其他综合收益15,242,181.5413,272,729.33-14,870,468.8129,805,821.2
综合收益总额581,891,870.63295,508,328.26125,746,509.442,872,789,700.59
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计8,602,262,763.268,867,486,530.310,124,855,451.8310,659,634,227.24
非流动资产合计3,560,789,685.723,363,605,901.523,284,514,467.513,231,073,610.5
资产总计12,163,052,448.9812,231,092,431.8213,409,369,919.3413,890,707,837.74
流动负债合计2,946,558,088.073,396,900,140.253,976,246,934.174,580,424,057.93
非流动负债合计539,735,869.34459,597,900.54411,955,968.95435,456,255.08
负债合计3,486,293,957.413,856,498,040.794,388,202,903.125,015,880,313.01
归属于母公司股东权益合计8,475,913,707.578,132,422,609.588,786,070,547.038,631,454,886.12
股东权益合计8,676,758,491.578,374,594,391.039,021,167,016.228,874,827,524.73
负债和股东权益合计12,163,052,448.9812,231,092,431.8213,409,369,919.3413,890,707,837.74
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计7,070,111,543.344,799,744,693.142,471,627,822.2313,152,981,430.79
经营活动现金流出小计6,562,300,401.584,446,113,886.812,251,805,368.1811,205,138,692.11
经营活动产生的现金流量净额507,811,141.76353,630,806.33219,822,454.051,947,842,738.68
投资活动现金流入小计218,532,762.44151,068.29138,49632,497,783.26
投资活动现金流出小计702,668,175.72301,830,359.51143,647,039.49880,867,215.11
投资活动产生的现金流量净额-484,135,413.28-301,679,291.22-143,508,543.49-848,369,431.85
筹资活动现金流入小计226,210,832.578,934,8654,484,865128,156,397.5
筹资活动现金流出小计1,138,747,204.541,078,351,627.2153,721,675.89996,723,153.94
筹资活动产生的现金流量净额-912,536,372.04-999,416,762.21-49,236,810.89-868,566,756.44
汇率变动对现金及现金等价物的影响20,978,760.8224,153,801.15-8,414,720.1538,949,133.47
现金及现金等价物净增加额-867,881,882.74-923,311,445.9518,662,379.52269,855,683.86
期末现金及现金等价物余额2,040,134,971.611,984,705,408.42,926,679,233.872,908,016,854.35
最新报告期:2024-02-19
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
国泰君安丁丹,赵峻峰1.402.143.172024-02-19
国泰君安丁丹,赵峻峰1.402.143.172024-02-19
中泰证券谢木青1.422.363.042024-02-01
中泰证券谢木青1.422.363.042024-02-01
中金公司张琎1.462.212.752024-01-31
TOP↑